Home > Insider Trading > Filing (0001171843-16-010579)

Filing Details

Accession Number:: 0001171843-16-010579
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-08 21:14:11
Reporting Period:: 2016-06-06

Filing Date:: 2016-06-08
Accepted Time:: 2016-06-08 21:14:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722830	Immunomedics Inc	IMMU	In Vitro & In Vivo Diagnostic Substances (2835)	611009366

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202016	L Cynthia Goldenberg	C/O Immunomedics, Inc. 300 The American Road Morris Plains NJ 07950	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-06	63,959	$2.50	703,029	No	4	M	Direct
Common Stock	Disposition	2016-06-06	63,959	$4.09	639,070	No	4	S	Direct
Common Stock	Acquisiton	2016-06-06	110,322	$2.50	5,345,784	No	4	M	Indirect	See footnote
Common Stock	Disposition	2016-06-06	110,322	$4.09	5,235,462	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2016-06-07	4,600	$2.50	643,670	No	4	M	Direct
Common Stock	Disposition	2016-06-07	4,600	$4.01	639,070	No	4	S	Direct
Common Stock	Acquisiton	2016-06-07	12,300	$2.50	5,247,762	No	4	M	Indirect	See footnote
Common Stock	Disposition	2016-06-07	12,300	$3.98	5,235,462	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2016-06-08	31,441	$2.50	670,511	No	4	M	Direct
Common Stock	Acquisiton	2016-06-08	10,000	$2.63	680,511	No	4	M	Direct
Common Stock	Disposition	2016-06-08	41,441	$3.62	639,070	No	4	S	Direct
Common Stock	Acquisiton	2016-06-08	120,388	$2.50	5,355,850	No	4	M	Indirect	See footnote
Common Stock	Disposition	2016-06-08	120,388	$3.64	5,235,462	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	M	Direct
No	4	S	Direct
No	4	M	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2016-06-06	63,959	$0.00	63,959	$2.50
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2016-06-06	110,322	$0.00	110,322	$2.50
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2016-06-07	4,600	$0.00	4,600	$2.50
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2016-06-07	12,300	$0.00	12,300	$2.50
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2016-06-08	31,441	$0.00	31,441	$2.50
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2016-06-08	10,000	$0.00	10,000	$2.63
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2016-06-08	120,388	$0.00	120,388	$2.50

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
36,041	2016-06-10	No	4	M	Direct
214,678	2016-06-10	No	4	M	Indirect
31,441	2016-06-10	No	4	M	Direct
202,378	2016-06-10	No	4	M	Indirect
0	2016-06-10	No	4	M	Direct
140,000	2016-06-14	No	4	M	Direct
81,990	2016-06-10	No	4	M	Indirect

Footnotes

Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Medical Officer and Chairman of the Board of Directors.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.00 to $4.45.
The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.00 to $4.02.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.96 to $4.02.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.6041 to $3.67.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.6041 to $3.685.
These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan.
These stock options were granted pursuant to the Issuer's 2002 Stock Option Plan, and vested over four years at a rate of 25% per year.